2024 UK Hospital Infectious Disease Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new report from LeadingMarketResearch.com contains 886 pages and 67 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.;Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.;Volume and sales forecasts for 80 infectious disease tests performed in UK hospital laboratories.;Instrumentation technologies and feature comparison of leading analyzers.;Sales and market shares of leading suppliers.;Emerging diagnostic technologies and their potential market applications.;Product development opportunities.;Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.;Business opportunities and strategic recommendations for suppliers.Contains 886 pages and 67 tables
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
More Publications
2018 UK Coagulation Testing Market: Sales and Market Shares of Major Reagent and Instrument Suppliers by Product
US$ 2,400.00
June 2018
77 pages
2020 UK Hospital Hemostasis Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers
US$ 3,500.00
January 2020
402 pages
U.K. 8 Respiratory Diseases, 2019-2023: Supplier Shares and Country Segment Forecasts, 2019-2023
US$ 1,950.00
July 2019
281 pages
2017-2021 UK Microbiology Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers
US$ 6,030.00
February 2017
978 pages